Status:
NOT_YET_RECRUITING
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Femoral Neck Fractures
Femur Head Necrosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to study the analgesic effect of liposomal bupivacaine plus bupivacaine for Pericapsular Nerve Group (PENG) block in postoperative pain management following hip repl...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists(ASA) I\~II
- Normal coagulation
- Clinical diagnosis of hip fracture
Exclusion
- Presence of severe systemic diseases or ASA grade III or higher
- Allergy to amide local anesthetics
Key Trial Info
Start Date :
September 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06565910
Start Date
September 15 2024
End Date
February 1 2025
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, HUST
Wuhan, Hubei, China, 430030